Medicare Part D Update — Lessons Learned and Unfinished Business
- 23 July 2009
- journal article
- editorial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 361 (4), 406-414
- https://doi.org/10.1056/nejmhpr0809949
Abstract
Since 2006, more than 40 million elderly and disabled people have had the opportunity to enroll in a Medicare Part D prescription-drug plan, as established under the Medicare Modernization Act (MMA) of 2003. Members of Congress, deeply divided by policy and ideological differences, debated several features of the proposed legislation before its passage.1 Issues that received particular scrutiny were the unprecedented way that the benefit would be delivered (exclusively through private plans) and its design, featuring an unusual gap in coverage (sometimes called the “doughnut hole”). Policymakers questioned whether insurance companies would be willing to offer stand-alone drug plans, how many beneficiaries would choose to enroll in a voluntary program, and how the program would affect drug prices and overall Medicare spending.2This publication has 15 references indexed in Scilit:
- The Effect Of Medicare Part D Coverage On Drug Use And Cost Sharing Among Seniors Without Prior Drug BenefitsHealth Affairs, 2009
- The Effect of the Medicare Part D Prescription Benefit on Drug Utilization and ExpendituresAnnals of Internal Medicine, 2008
- Should Drug Prices Be Negotiated Under Part D Of Medicare? And If So, How?Health Affairs, 2008
- The Impact Of Medicare Part D On Prescription Drug Use By The ElderlyHealth Affairs, 2007
- Medicare Prescription Drug Benefit Progress Report: Findings From A 2006 National Survey Of SeniorsHealth Affairs, 2007
- Cost-Related Medication Nonadherence Among Elderly and Disabled Medicare BeneficiariesArchives of Internal Medicine, 2006
- Status Report On Medicare Part D Enrollment In 2006: Analysis Of Plan-Specific Market Share And CoverageHealth Affairs, 2006
- Who Failed To Enroll In Medicare Part D, And Why? Early ResultsHealth Affairs, 2006
- The New Medicare Prescription-Drug Benefit — A Pure Power PlayNew England Journal of Medicine, 2004
- The New Medicare Prescription-Drug LegislationNew England Journal of Medicine, 2004